Posterior Uveitis Causes and Regional Risk Factors

Epidemiology and Regional Patterns

Posterior uveitis accounts for roughly 15–20 % of all uveitis cases worldwide, yet its prevalence varies markedly by region. In North America and Europe, the incidence is estimated at 5–7 per 100,000 people annually, while in parts of Latin America and Africa it may rise to 10–15 per 100,000. These disparities reflect differences in underlying disease distributions, diagnostic practices, and access to ophthalmic care.

Age and sex influence the burden of posterior uveitis. Most patients present between 30 and 60 years, with a slight male predominance in some regions, possibly linked to occupational exposures. Rural populations in low‑income countries often report later diagnoses, contributing to higher severity at presentation.

National registries, such as the Uveitis Registry of North America and the European Uveitis Working Group database, provide granular data that reveal distinct regional trends. For example, the Uveitis Registry shows a higher proportion of infectious causes in South America, whereas the European database reports a larger share of autoimmune etiologies. These differences underscore the importance of region‑specific surveillance.

Infectious Causes Across Continents

The leading infectious agents behind posterior uveitis differ by geography. Toxoplasma gondii remains the most common culprit in Latin America, often presenting as multifocal retinochoroiditis. In contrast, tuberculosis, caused by Mycobacterium tuberculosis, is a frequent cause in Asia and parts of Africa, particularly among individuals with latent infection who develop ocular manifestations during reactivation.

Herpesviruses, especially cytomegalovirus and herpes simplex virus, are predominant in North America and Europe, frequently affecting immunocompromised patients. Syphilis, though less common overall, can produce posterior segment inflammation in areas with high rates of sexually transmitted infections, such as certain urban centers worldwide.

Diagnosing infectious posterior uveitis relies on region‑appropriate testing. In high‑TB prevalence settings, interferon‑γ release assays and chest imaging are routine, whereas in low‑TB areas clinicians focus more on serology for toxoplasmosis and PCR for viral DNA. The choice of tests reflects local disease burdens and resource availability.

Autoimmune and Systemic Associations by Region

Autoimmune diseases are a major source of posterior uveitis, with sarcoidosis, Behçet’s disease, multiple sclerosis, and inflammatory bowel disease among the most common systemic links. The prevalence of these conditions varies geographically, shaping the profile of posterior uveitis seen in different populations.

Sarcoidosis shows a higher incidence in African‑American and Scandinavian groups, while Behçet’s disease is endemic along the ancient Silk Road, affecting Middle Eastern and Southeast Asian populations. Multiple sclerosis, a frequent cause of posterior uveitis in the eye, peaks in Northern European countries and among people of Northern European descent.

Effective management of the underlying systemic disease often reduces ocular flare‑ups. In regions where systemic therapy is widely available, the rate of posterior uveitis associated with these conditions tends to decline, highlighting the role of integrated care pathways in mitigating ocular complications.

Environmental and Occupational Triggers

Environmental factors such as high ultraviolet exposure, extreme altitudes, and dry climates can exacerbate ocular inflammation. Individuals working in outdoor settings without adequate eye protection are more likely to develop retinal edema and secondary uveitis.

Occupational exposures to silica dust, metal fumes, and agricultural chemicals contribute to a subset of posterior uveitis cases. Workers in mining, construction, and farming industries often report ocular complaints that progress to posterior segment involvement, especially when protective eyewear is inadequate or poorly fitted.

Regional variations emerge when these exposures intersect with local industry profiles. For instance, Australian coastal workers face intense UV radiation, South African miners are exposed to silica, and Central American agricultural laborers encounter pesticides. Public health initiatives tailored to these environments can reduce the incidence of occupationally related ocular inflammation.

Genetic Predispositions and Ethnic Variations

Genetic susceptibility plays a pivotal role in posterior uveitis risk. Certain human leukocyte antigen (HLA) alleles, such as HLA‑B27, are strongly associated with ankylosing spondylitis and its ocular manifestations, while HLA‑DRB1 alleles are linked to Behçet’s disease in Asian populations.

Ethnic differences in allele frequencies account for regional disparities in disease prevalence. For example, HLA‑B27 is common among Northern Europeans and African‑Americans, explaining the higher rates of HLA‑B27–associated uveitis in those groups. Conversely, specific HLA‑DRB1 variants are prevalent in Middle Eastern cohorts, aligning with the high incidence of Behçet’s disease there.

These genetic insights inform screening strategies. Populations with known high‑risk alleles may benefit from early ophthalmic evaluation, especially when systemic autoimmune disease is diagnosed. Genetic counseling and targeted monitoring can help mitigate the progression to severe posterior uveitis.